Infections with herpes simplex virus (HSV) are common in children with human immunodeficiency virus (HIV) infection and can be severe and atypical.1 Herein, we report a case of a progressive wound of the hand associated with HSV type 1 in a child with the acquired immunodeficiency syndrome (AIDS).
Get full access to this article
View all access options for this article.
References
1.
Prose NSHuman immunodeficiency virus infection in childhood: the disease and its cutaneous manifestations. AdvDermatol. 1990;5:113-130.
2.
Straka BF, Whitaker DL, Morrison SH, et al. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol.1988;18:1089-1102.
3.
VesteyJP, Norval M.Mucocutaneous infections with herpes simplex virus and their management . Clin Exp Dermatol.1992;17:221-237.
4.
Kohl S.Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections. Rev Infect Dis.1991;13:108-114.
5.
Solomon AR, Rasmussen JE, Varani J., Pierson CLThe Tzanck smear in the diagnosis of cutaneous herpes simplex. JAMA.1984;251:633-635.
6.
Motyl MR, Bottone EJ, Janda JMDiagnosis of herpes virus infections: correlation of Tzanck preparations with viral isolation. Diagn Microbiol Infect Dis.1984;2:157-160.
7.
Hardy WDFoscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled randomized, regimen-comparative trial. Am J Med.1992;92 (suppl 2A):2A-30S-35S.
8.
Birch CJ, Tyssen DP, Tachedjian G., et al. Clinical effects and in-vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug resistant and sensitive herpes simplex virus infections. J Infect Dis. 1992;166: 108-112.
9.
Sarah R.Management of mucocutaneous herpes simplex virus infections in immunocompromised patients. Am J Med.1988;85 (suppl 2A):57-60.
10.
Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis . Ann Intern Med.1993;118:268-272.